Companies /Healthcare

First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued

NASDAQ: TRAXV Biotechnology
$22.51
▲ $0.00 (+0.00%) today
Markets open · 3:22pm ET

Fundamentals

Market Cap
$782.2M
52-Week Range
$15 – $27

About TRAXV

First Tracks Biotherapeutics, Inc. is a clinical-stage biotechnology company developing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases. The company is headquartered in San Diego, California.

TRAXV Coverage